Exact Mass: 514.2930382
Exact Mass Matches: 514.2930382
Found 500 metabolites which its exact mass value is equals to given mass value 514.2930382
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
elatericin B
Cucurbitacin I is a cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. It has a role as a plant metabolite and an antineoplastic agent. It is a cucurbitacin and a tertiary alpha-hydroxy ketone. Cucurbitacin I is a natural product found in Elaeocarpus chinensis, Elaeocarpus hainanensis, and other organisms with data available. A cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
stigmatellin
A member of the class of chromones that is isolated from Stigmatella aurantiaca Sg a15. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Ganoderic acid J
Ganoderic acid J is found in mushrooms. Ganoderic acid J is a metabolite of Ganoderma lucidum (reishi).
Ganoderenic acid B
Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderic acid C1
Ganoderic acid C1 is found in mushrooms. Ganoderic acid C1 is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid C1 is found in mushrooms. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Ganoderenic acid A
Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid xi
Ganoderic acid xi is found in mushrooms. Ganoderic acid xi is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid xi is found in mushrooms.
Cofaryloside
Cofaryloside is found in coffee and coffee products. Cofaryloside is a constituent of green coffee beans Constituent of green coffee beans. Cofaryloside is found in coffee and coffee products.
Flavidulol C
Flavidulol C is found in mushrooms. Flavidulol C is isolated from the edible, but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Isolated from the edible, but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Flavidulol C is found in mushrooms.
Ganoderic acid V1
Ganoderic acid V1 is found in mushrooms. Ganoderic acid V1 is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid V1 is found in mushrooms.
Ganosporelactone B
Ganosporelactone B is found in mushrooms. Ganosporelactone B is isolated from the spores of Ganoderma lucidum (reishi).
Capsianoside V
Constituent of fruits of Capsicum annuum variety grossum. Capsianoside V is found in many foods, some of which are orange bell pepper, italian sweet red pepper, red bell pepper, and fruits. Capsianoside V is found in fruits. Capsianoside V is a constituent of fruits of Capsicum annuum var. grossum
Cinncassiol D1 glucoside
Cinncassiol D1 glucoside is found in herbs and spices. Cinncassiol D1 glucoside is a constituent of Cinnamomum cassia (Chinese cinnamon) Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol D1 glucoside is found in herbs and spices.
Cinncassiol D4 2-glucoside
Cinncassiol D4 2-glucoside is found in herbs and spices. Cinncassiol D4 2-glucoside is a constituent of Cinnamomum cassia (Chinese cinnamon) Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol D4 2-glucoside is found in herbs and spices.
N-Docosahexaenoyl Tryptophan
N-docosahexaenoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Tryptophan is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Cucurbitacin I
Ganoderic acid D
Ganoderic acid C1 is a triterpenoid. Ganoderic acid C1 is a natural product found in Ganoderma lucidum with data available. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Laulimalide
A macrolide with formula C30H42O7 that is isolated from the marine sponges, Cacospongia mycofijiensis and Hyattella sp.
Ganoderic acid D
Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Anhydrocochlioquinone A
[Raw Data] CBA28_Anhydrocochlioq_pos_50eV_1-2_01_1556.txt [Raw Data] CBA28_Anhydrocochlioq_pos_40eV_1-2_01_1555.txt [Raw Data] CBA28_Anhydrocochlioq_pos_30eV_1-2_01_1554.txt [Raw Data] CBA28_Anhydrocochlioq_pos_20eV_1-2_01_1553.txt [Raw Data] CBA28_Anhydrocochlioq_pos_10eV_1-2_01_1541.txt
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-16alpha-acetoxywitha-2-enolide
3beta-O-(beta-D-sarmentosyl)-8,14-epoxy-5beta,14beta-card-16,20(22)-dienolide|cardenolide N-2
Cucurbitacin I
Cucurbitacin i is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin i is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin i can be found in cucumber, which makes cucurbitacin i a potential biomarker for the consumption of this food product. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
7??,23?鈥?Dihydroxy-3,11,15-trioxolanosta-8,20E(22)-dien-26-oic acid
methyl 7beta-hydroxy-3,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oate
(5alpha,6beta,18S,22R)-18,20-epoxy-6,22-dihydroxy-5,18-dimethoxy-1-oxoergosta-2,24-dien-26-oic acid delta-lactone|5-O-methoxywithaphysalin R
3,7,11,15,23-pentaoxolanostan-26-oic acid|8beta,9alpha-dihydroganoderic acid C
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-18-acetoxywitha-2-enolide
12-O-tiglyl-4-deoxy-4alpha-phorbol-13-(2-methyl)butyrate
7alpha,12alpha,14beta,15alpha-tetrahydroxyl-ent-kaur-16-ene-1-O-beta-D-glucopyranoside|glaucocalyxin G
(20R)-5alpha-pregnane-2alpha,3alpha,16beta,20-tetrol 2-O-beta-D-glucopyranoside
3beta(H)-1-oxo-7beta,9alpha,13-triangelyloxylongipinane
craiobioside B|craiobiotoxin VIII 3-O-beta-D-glucopyranoside
eudesm-11-en-4alpha-O-beta-D-2-cinnamoyloxy-glucopyranoside|fissipallin
(3beta,5beta,6beta,18S,22R)-5,6:18,20-diepoxy-22-hydroxy-3,18-dimethoxy-1-oxoergost-24-en-26-oic acid delta-lactone|withaphysalin Q
(4aR)-9-((1S)-2cF-Acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthen-8,11-dion|(4aR)-9-((1S)-2cF-acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthene-8,11-dione|anhydroisocochlioquinone A
10(20)-grayanotoxene-3beta,5beta,6beta,14beta,16alpha-pentol 3-O-beta-D-glucopyranoside|rhodomoside A
Ganoderic acid LM2
Ganoderenic acid B
Ganoderenic acid B is a triterpenoid. CID 78074039 is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderenic acid A
Ganoderenic acid A is a triterpenoid. (E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid J
C27H46O9_9,12,15-Octadecatrienoic acid, 3-(hexopyranosyloxy)-2-hydroxypropyl ester, (9Z,12Z,15Z)
C28H38N2O7_Spiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalene]-7(3H)-acetic acid, alpha-(3-amino-3-oxopropyl)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxo
C28H38N2O7 (514.2678877999999)
5-amino-2-(3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl)-5-oxopentanoic acid
C28H38N2O7 (514.2678877999999)
5-amino-2-(3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl)-5-oxopentanoic acid_major
C28H38N2O7 (514.2678877999999)
5-amino-2-(3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl)-5-oxopentanoic acid_88.2\\%
C28H38N2O7 (514.2678877999999)
Cys His Lys Lys
Cys Lys His Lys
Cys Lys Lys His
Asp Lys Pro Arg
Asp Lys Arg Pro
Asp Pro Lys Arg
Asp Pro Arg Lys
Asp Arg Lys Pro
Asp Arg Pro Lys
Phe His Ile Val
C26H38N6O5 (514.2903537999999)
Phe His Leu Val
C26H38N6O5 (514.2903537999999)
Phe His Val Ile
C26H38N6O5 (514.2903537999999)
Phe His Val Leu
C26H38N6O5 (514.2903537999999)
Phe Ile His Val
C26H38N6O5 (514.2903537999999)
Phe Ile Val His
C26H38N6O5 (514.2903537999999)
Phe Leu His Val
C26H38N6O5 (514.2903537999999)
Phe Leu Val His
C26H38N6O5 (514.2903537999999)
Phe Val His Ile
C26H38N6O5 (514.2903537999999)
Phe Val His Leu
C26H38N6O5 (514.2903537999999)
Phe Val Ile His
C26H38N6O5 (514.2903537999999)
Phe Val Leu His
C26H38N6O5 (514.2903537999999)
Gly Pro Arg Trp
Gly Pro Trp Arg
Gly Arg Pro Trp
Gly Arg Trp Pro
Gly Trp Pro Arg
Gly Trp Arg Pro
His Cys Lys Lys
His Phe Ile Val
C26H38N6O5 (514.2903537999999)
His Phe Leu Val
C26H38N6O5 (514.2903537999999)
His Phe Val Ile
C26H38N6O5 (514.2903537999999)
His Phe Val Leu
C26H38N6O5 (514.2903537999999)
His Ile Phe Val
C26H38N6O5 (514.2903537999999)
His Ile Val Phe
C26H38N6O5 (514.2903537999999)
His Lys Cys Lys
His Lys Lys Cys
His Leu Phe Val
C26H38N6O5 (514.2903537999999)
His Leu Val Phe
C26H38N6O5 (514.2903537999999)
His Val Phe Ile
C26H38N6O5 (514.2903537999999)
His Val Phe Leu
C26H38N6O5 (514.2903537999999)
His Val Ile Phe
C26H38N6O5 (514.2903537999999)
His Val Leu Phe
C26H38N6O5 (514.2903537999999)
Ile Phe His Val
C26H38N6O5 (514.2903537999999)
Ile Phe Val His
C26H38N6O5 (514.2903537999999)
Ile His Phe Val
C26H38N6O5 (514.2903537999999)
Ile His Val Phe
C26H38N6O5 (514.2903537999999)
Ile Ile Asn Arg
Ile Ile Arg Asn
Ile Leu Asn Arg
Ile Leu Arg Asn
Ile Asn Ile Arg
Ile Asn Leu Arg
Ile Asn Arg Ile
Ile Asn Arg Leu
Ile Gln Arg Val
Ile Val Phe His
C26H38N6O5 (514.2903537999999)
Ile Val His Phe
C26H38N6O5 (514.2903537999999)
Lys Cys His Lys
Lys Cys Lys His
Lys Asp Pro Arg
Lys Asp Arg Pro
Lys His Cys Lys
Lys His Lys Cys
Lys Lys Cys His
Lys Lys His Cys
Lys Pro Asp Arg
Lys Pro Arg Asp
Lys Arg Asp Pro
Lys Arg Pro Asp
Leu Phe His Val
C26H38N6O5 (514.2903537999999)
Leu Phe Val His
C26H38N6O5 (514.2903537999999)
Leu His Phe Val
C26H38N6O5 (514.2903537999999)
Leu His Val Phe
C26H38N6O5 (514.2903537999999)
Leu Val Phe His
C26H38N6O5 (514.2903537999999)
Leu Val His Phe
C26H38N6O5 (514.2903537999999)
Pro Asp Lys Arg
Pro Asp Arg Lys
Pro Gly Arg Trp
Pro Gly Trp Arg
Pro Lys Asp Arg
Pro Lys Arg Asp
Pro Arg Asp Lys
Pro Arg Gly Trp
Pro Arg Lys Asp
Pro Arg Arg Ser
C20H38N10O6 (514.2975647999999)
Pro Arg Ser Arg
C20H38N10O6 (514.2975647999999)
Pro Arg Trp Gly
Pro Ser Arg Arg
C20H38N10O6 (514.2975647999999)
Pro Trp Gly Arg
Pro Trp Arg Gly
Arg Asp Lys Pro
Arg Asp Pro Lys
Arg Gly Pro Trp
Arg Gly Trp Pro
Arg Lys Asp Pro
Arg Lys Pro Asp
Arg Pro Asp Lys
Arg Pro Gly Trp
Arg Pro Lys Asp
Arg Pro Arg Ser
C20H38N10O6 (514.2975647999999)
Arg Pro Ser Arg
C20H38N10O6 (514.2975647999999)
Arg Pro Trp Gly
Arg Arg Pro Ser
C20H38N10O6 (514.2975647999999)
Arg Arg Ser Pro
C20H38N10O6 (514.2975647999999)
Arg Ser Pro Arg
C20H38N10O6 (514.2975647999999)
Arg Ser Arg Pro
C20H38N10O6 (514.2975647999999)
Arg Trp Gly Pro
Arg Trp Pro Gly
Ser Pro Arg Arg
C20H38N10O6 (514.2975647999999)
Ser Arg Pro Arg
C20H38N10O6 (514.2975647999999)
Ser Arg Arg Pro
C20H38N10O6 (514.2975647999999)
Val Phe His Ile
C26H38N6O5 (514.2903537999999)
Val Phe His Leu
C26H38N6O5 (514.2903537999999)
Val Phe Ile His
C26H38N6O5 (514.2903537999999)
Val Phe Leu His
C26H38N6O5 (514.2903537999999)
Val His Phe Ile
C26H38N6O5 (514.2903537999999)
Val His Phe Leu
C26H38N6O5 (514.2903537999999)
Val His Ile Phe
C26H38N6O5 (514.2903537999999)
Val His Leu Phe
C26H38N6O5 (514.2903537999999)
Val Ile Phe His
C26H38N6O5 (514.2903537999999)
Val Ile His Phe
C26H38N6O5 (514.2903537999999)
Val Leu Phe His
C26H38N6O5 (514.2903537999999)
Val Leu His Phe
C26H38N6O5 (514.2903537999999)
Trp Gly Pro Arg
Trp Gly Arg Pro
Trp Pro Gly Arg
Trp Pro Arg Gly
Trp Arg Gly Pro
Trp Arg Pro Gly
Capsianside V
Cinncassiol D1 glucoside
Cinncassiol D4 2-glucoside
Cofaryloside
Ganoderic acid C
Ganoderic acid Z
Ganosporelactone B
Flavidulol C
Ganoderic acid V1
tert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate hemioxalate
3-[2-(4-Aminophenyl)ethyl]-8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-
Tauro-beta-muricholate
A cholanic acid conjugate anion that is the conjugate base of tauro-beta-muricholic acid arising from deprotonation of the sulfonate OH group; major species at pH 7.3. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
9-[(E)-4-[(2S,4R,5R)-4,5-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]-3-oxooxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
17-[(E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
Tauro-alpha-muricholate(1-)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
(3S,3aR,4S,6aS,7E,10S,11E,13R,14S,15Z,17aS)-13,14-dihydroxy-3-(1H-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3,3a,4,6a,9,10,13,14-octahydro-1H-cyclotrideca[d]isoindole-1,17(2H)-dione
Tauroursocholate
An organosulfonate oxoanion that is the conjugate base of tauroursocholic acid, obtained by the deprotonation of the sulfonic acid group. It is the major microspecies at pH 7.3.
(2S)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2S)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2S)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
2-(dimethylamino)-N-[(4R,7R,8S)-5-[(2-fluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C28H39FN4O4 (514.2955185999999)
(2S)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2S)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2R,4aS,12aS)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
(2R)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2R,4aR,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aR,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aR,12aR)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
3-cyclohexyl-1-[[(2R,3S)-8-(3-hydroxyhex-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
(2S)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2R,4aS,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aR,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
(2S)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2S,4aS,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
(2R)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(Z)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid
(8S,9R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
[2-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate
(2-hydroxy-3-phosphonooxypropyl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
2-[hydroxy-[2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
eurysterol A sulfonic acid
A steroid sulfate that is 5alpha-cholestane substituted by hydroxy groups at positions 5 and 6, a bridged oxolane at positions 8 and 19 pand a sulfate group at position 3.
Taurocholate
An organosulfonate oxoanion that is the conjugate base of taurocholic acid.
LPEt(22:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
15-[1-(4,5-dimethyl-6-oxooxan-2-yl)ethyl]-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2r,5z)-6-[(1s,3as,4r,5as,7r,9ar,11as)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2z)-6-[(1r,3s,3ar,4s,5ar,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylhepta-2,6-dienoic acid
(2s,5e)-6-[(1r,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2r,6s)-6-[(1r,3ar,4s,5ar,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
2-[(3r,4s,5s,6s,7e,9e,11e)-4,6-dimethoxy-3,5,11-trimethyltrideca-7,9,11-trien-1-yl]-8-hydroxy-5,7-dimethoxy-3-methylchromen-4-one
(2s,3s)-1-[(3s,7s,10s,13e)-10-[(2s)-butan-2-yl]-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-methylpentan-1-one
(2r,3r,4s,5s,6r)-2-{[(1s,2s,3as,3br,5as,7s,8r,9as,9bs,11as)-2,7-dihydroxy-1-[(1r)-1-hydroxyethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,6r)-6-[(1r,3as,3br,5ar,9as,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
3,4-dihydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-5'',7,10-trione
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5r,9s,10r,13s,14s)-13,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione
(1s,4s,5r,8s,9s,10r,13r,14r)-14-hydroxy-14-(hydroxymethyl)-5,9-dimethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
5'-(1-{1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-6',10'-dimethyl-13'-oxaspiro[oxolane-2,11'-tetracyclo[7.5.0.0²,⁶.0¹²,¹⁴]tetradecan]-8'-ene-5,7'-dione
(3s,3ar,4s,6as,10s,13r,17ar)-1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione
(6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
6-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxohept-5-enoic acid
(1r,3r,4r,6s,8s,10s,13r,14r)-5,5,14-trimethyl-9-methylidene-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,10,14-tetrol
(1r,4s,5s,6r,9s,10s,13r,14r,15r)-6,14,15-trihydroxy-5,9-dimethyl-14-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde
4,6-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-(6-hydroxy-1-benzofuran-2-yl)benzene-1,3-diol
6-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoic acid
(1r,3e,5r,7s,9r,10e,12s,13s,14r)-1-(acetyloxy)-13-hydroxy-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-9-yl (2e)-3-[(2s,3r)-3-propyloxiran-2-yl]prop-2-enoate
(3s,3as,6r,7ar)-5-{5-[(5r,6s,7as)-6-ethenyl-3-(hydroxymethyl)-6-methyl-2-oxo-4,5,7,7a-tetrahydro-1-benzofuran-5-yl]hex-5-en-2-yl}-6-ethyl-3-hydroxy-3-(hydroxymethyl)-6-methyl-7,7a-dihydro-3ah-1-benzofuran-2-one
7-hydroxy-12-[1-hydroxy-3-(4-methyl-3,6-dihydro-2h-pyran-2-yl)prop-2-en-1-yl]-3-methyl-5-methylidene-9,13,22-trioxatricyclo[16.3.1.0⁸,¹⁰]docosa-15,19-dien-14-one
15-(1-{2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl}ethyl)-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2s,3s,4s)-2-[(2r,4ar,10ar,12ar)-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-6,9-dioxo-2,3,4,11,12,12a-hexahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate
4,4',6,12,17,17-hexamethyl-9,18,23,24-tetraoxaspiro[hexacyclo[20.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰.0¹⁶,²²]pentacosane-8,2'-oxolan]-20-ene-5',19-dione
7β,23ξ-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid
{"Ingredient_id": "HBIN013082","Ingredient_name": "7\u03b2,23\u03be-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid","Alias": "NA","Ingredient_formula": "C30H42O7","Ingredient_Smile": "CC(CC(C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2e,4r,6e,10z,14s)-4-hydroxy-10-(hydroxymethyl)-2,6,14-trimethyl-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-2,6,10,15-tetraenoic acid
7,12-dihydroxy-3-methyl-13-[2-(4-methyl-3,6-dihydro-2h-pyran-2-yl)ethenyl]-5-methylidene-9,14,23-trioxatricyclo[17.3.1.0⁸,¹⁰]tricosa-16,20-dien-15-one
(2e,6r)-6-[(1r,3as,5as,7r,9ar,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methylhept-2-enoic acid
(1s,2e,4e,6s,7r,8s,11r,12e,14e,16r,17r,18r,19s)-8-{[(2s,3r,4r,5r)-3-amino-4,5-dihydroxyoxan-2-yl]oxy}-7,18-dihydroxy-7,19-dimethyl-21-azatetracyclo[14.6.0.0⁶,¹¹.0¹⁷,²¹]docosa-2,4,9,12,14-pentaen-22-one
C28H38N2O7 (514.2678877999999)
2-(4,6-dimethoxy-3,5,11-trimethyltrideca-7,9,11-trien-1-yl)-8-hydroxy-5,7-dimethoxy-3-methylchromen-4-one
(2r)-2-hydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl (9z,12e,15e)-octadeca-9,12,15-trienoate
(6r)-6-[(1r,3ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
(2r,6r)-6-[(1r,3ar,4s,5as,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
(1s,2s,5s,6r,8s,9r,12s,13r,16r,18s,20r)-6-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-8,16-dimethoxy-6,13-dimethyl-7,19-dioxahexacyclo[10.9.0.0²,⁹.0⁵,⁹.0¹³,¹⁸.0¹⁸,²⁰]henicosan-14-one
(1s,2s,5s,6r,8s,9r,12s,13r,18r,19r)-6-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-19-hydroxy-8,18-dimethoxy-6,13-dimethyl-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-15-en-14-one
(2r,6r)-6-[(1r,3ar,4s,5ar,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
(1r,2s,11s,14s,15r,16r,18s,20s)-18-(acetyloxy)-1,7,11,15,19,19-hexamethyl-5-oxo-8,10-dioxapentacyclo[12.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]docosa-4(9),6-dien-16-yl acetate
1-(acetyloxy)-13-hydroxy-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-9-yl 3-(3-propyloxiran-2-yl)prop-2-enoate
(6r)-6-[(3s,3ar,5ar,7s,9as,11ar)-3,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4,10-dioxo-3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
11,12-dihydroxy-16-methyl-8-[2-(4-methyl-3,6-dihydro-2h-pyran-2-yl)ethenyl]-14-methylidene-6,9,22-trioxatricyclo[16.3.1.1⁷,¹⁰]tricosa-3,20-dien-5-one
(1r,3r,7s,8s,10s,12s,15z,18r)-7-hydroxy-12-[(1s,2e)-1-hydroxy-3-[(2r)-4-methyl-3,6-dihydro-2h-pyran-2-yl]prop-2-en-1-yl]-3-methyl-5-methylidene-9,13,22-trioxatricyclo[16.3.1.0⁸,¹⁰]docosa-15,19-dien-14-one
(5e)-6-[(1s,3as,4r,5as,9ar,11as)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylhept-5-enoic acid
(2r,5z)-6-[(3s,3ar,4s,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
methyl 6-{4-hydroxy-6,6,9a,11a-tetramethyl-3,7,10-trioxo-1h,2h,3ah,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoate
(1s,4r,4'r,5r,6r,8s,10r,12s,13s,16s,22s)-4,4',6,12,17,17-hexamethyl-9,18,23,24-tetraoxaspiro[hexacyclo[20.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰.0¹⁶,²²]pentacosane-8,2'-oxolan]-20-ene-5',19-dione
2-{[2,7-dihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (2r,6r)-6-[(1r,3ar,4s,5ar,9as,11ar)-4-hydroxy-6,6,9a,11a-tetramethyl-3,7,10-trioxo-1h,2h,3ah,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate
(1s,3'r,3as,4s,4''s,5's,5ar,7s,9as,11as)-4,7-dihydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-2,4,5,5a,7,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-3,5'',10-trione
9-benzyl-1,4,7-trihydroxy-3-(6-hydroxyoctyl)-6-methyl-3h,6h,9h,12h,13h,14h,15h,15ah-pyrido[1,2-a]1,4,7,10-tetraazacyclododecan-10-one
(6r)-6-[(1r,3s,3ar,5ar,9as,11ar)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoic acid
(1r,2r,3r,6e,8s,10e,12e,15r,16e,18r,19s)-15-hydroxy-19-methoxy-2,6,8,10,16-pentamethyl-3-[(1e)-2-[(2r,3r)-3-methyloxiran-2-yl]ethenyl]-4,21-dioxabicyclo[16.2.1]henicosa-6,10,12,16-tetraene-5,9-dione
(6r)-6-[(2r,3s,7r,9s,11r,14r,15r,17r)-9,17-dihydroxy-2,6,6,11,15-pentamethyl-5,12-dioxopentacyclo[8.7.0.0²,⁷.0³,¹⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl]-2-methyl-4-oxoheptanoic acid
6-hydroxy-6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid
(3ar,4s,6as,10s,13r,17as)-1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione
(1s,3s,3'r,3as,4s,4''s,5's,5ar,9as,11as)-3,4-dihydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-5'',7,10-trione
2-[2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-6,9-dioxo-2,3,4,11,12,12a-hexahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate
(3e)-11,12-dihydroxy-16-methyl-8-[(1e)-2-(4-methyl-3,6-dihydro-2h-pyran-2-yl)ethenyl]-14-methylidene-6,9,22-trioxatricyclo[16.3.1.1⁷,¹⁰]tricosa-3,20-dien-5-one
n-[(2r,3s)-1-[(3s,7s,10s,13z)-10-[(2s)-butan-2-yl]-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-3-methyl-1-oxopentan-2-yl]carboximidic acid
4-hydroxy-6-{3-hydroxy-3a,6,6,9a,11a-pentamethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid
(1s,2r,7s,9r,11s,12s,14r,15r,16s)-15-[(1s)-1-[(1s,2r,4r,6s)-2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
4-hydroxy-6-{4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-5-enoic acid
{3,7,9-trimethyl-4,6-bis[(2-methylbut-2-enoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undecan-3-yl}methyl 2-methylbut-2-enoate
(1r,2r,4s,5s,9r,10s,12s,13r,14r,16r)-2,12,16-trihydroxy-5,9,14-trimethyl-5-({[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-one
(1'r,2r,2'r,5'r,6'r,10's,12's,14's)-5'-[(1s)-1-[(1s,3r,5r)-1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-6',10'-dimethyl-13'-oxaspiro[oxolane-2,11'-tetracyclo[7.5.0.0²,⁶.0¹²,¹⁴]tetradecan]-8'-ene-5,7'-dione
(5z)-6-[(3ar,4s,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2r,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
[(1s,2r,6s,7r,9r,11s,12s,15r,16r)-15-[(1s)-1-[(2r,4s,5r)-4,5-dimethyl-6-oxooxan-2-yl]ethyl]-6-hydroxy-2-methyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-16-yl]methyl acetate
6-{4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoic acid
(6r)-6-[(1r,3as,3br,5ar,9as,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
(2s,5z)-6-[(1r,3s,3ar,4s,5as,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
n-{1-[8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-3-methyl-1-oxopentan-2-yl}carboximidic acid
(1r,2s,12r,21ar)-13-{[(2s,3r,4r,5r)-3-amino-4,5-dihydroxyoxan-2-yl]oxy}-1,12-dihydroxy-2,12-dimethyl-1h,2h,3h,13h,21ah-pyrrolo[1,2-a]azacyclononadecan-5-one
C28H38N2O7 (514.2678877999999)